Edmonton, Alberta / TheNewswire / September 13, 2018 - BioNeutra Global Corporation ("BioNeutra" or the "Company") (TSXV: BGA), a functional and health food and beverage ingredient manufacturer producing isomalto-oligosaccharide ("IMO") using its patented processes, is pleased to announce that two of Canada's top business magazines, Canadian Business and Maclean's today jointly released the 30th annual ranking of Canada's 500 Fastest-Growing Companies placing BioNeutra North America Inc. ("BNA"), a wholly-owned subsidiary of the Company, at No. 1 in Edmonton and No. 55 overall in Canada. BNA also received a ranking of No. 10 on the list of the 88 manufacturing companies.
The magazines slotted BNA in the top 60 companies in Canada on its 2018 Growth 500 rankings based on the Company's five-year revenue growth of 1,378%. The ranking is the country's most definitive list of the fastest growing businesses in Canada.
BNA will be profiled with other winners in a special print issue of Canadian Business (packaged with the October issue of Maclean's magazine) and online at canadianbusiness.com and growth500.ca.
BNA is a growth leader among companies in Western Canada with revenue in the range of $20 million to $50 million. Last year BNA posted sales which averaged $500,000 a week and ended the year with revenue of approximately $32.1 million. This year, revenue jumped with sales averaging $900,000 per week for the first six months in 2018.
'Growth 500' organizers describe the companies that make its prestigious list as "entrepreneurial superstars" who are some of the most "innovative businesses" in the country.
"The companies on the 2018 Growth 500 are truly remarkable. Demonstrating foresight, innovation and smart management, their stories serve as a primer for how to build a successful entrepreneurial business today," says Deborah Aarts, Growth 500 editor and program manager. "As we celebrate 30 years of the Canada's Fastest-Growing Companies program, it's encouraging to see that entrepreneurship is healthier than ever in this country."
"BNA is honored to be recognized by the country's most highly regarded business ranking," says Dr. Jianhua Zhu, BioNeutra president, CEO and founder and adds, "but to be among the top 60 companies nationwide in our first ranking is a tribute to our outstanding team of dedicated, hard-working employees who continue to turn in a remarkable performance. We're grateful to them and our world-wide customers who have contributed to our success."
Board Chair and former Edmonton Mayor Bill Smith says, "BioNeutra's sales growth is off the charts. We're thrilled by the Company's performance and recognition as one of Canada's most successful growth businesses."
BioNeutra is a business and science awards leader. Earlier this year it was chosen for the third consecutive year by the Globe and Mail's Report On Business magazine for its list of Canada's top 1000 publicly traded companies ranked by revenue.
Visit www.bioneutra.ca; www.vitafiberimo.com; www.facebook.com/VitaFiberIMO
View the complete rankings of Canada's Fastest-Growing Companies at growth500.ca.
About the Growth-500
For 30 years, the Growth-500 has been Canada's most respected and influential ranking of entrepreneurial achievement. Ranking Canada's Fastest-Growing Companies by five-year revenue growth, the Growth 500 - formerly known as the PROFIT 500 - profiles the country's most successful growing businesses. The Growth 500 is produced by Canadian Business. Winners are profiled in a special Growth 500 print issue of Canadian Business (packaged with the October issue of Maclean's magazine) and online at growth500.ca and CanadianBusiness.com. For more information on the ranking, visit growth500.ca.
About Canadian Business
Founded in 1928, Canadian Business is the longest-serving and most-trusted business publication in the country. It is the country's premier media brand for executives and senior business leaders. It fuels the success of Canada's business elite with a focus on the things that matter most: leadership, innovation, business strategy and management tactics. Learn more at CanadianBusiness.com.
BioNeutra is a multiple-award winning, sector-leading, science-based company committed to improving public health. The media describes it as "...a rising star." Its lead product is VitaFiber - a healthy low-calorie sweetener which is a dietary fibre and is designed to help with two of the world's growing health problems - weight management and digestive health. VitaFiber, is the result of a patented process developed over 27 years and is approved for sale in 30 countries after the world's top three health regulators reviewed the body of science including a human trial submitted during the review process.
For further information, please contact:
BioNeutra North America Inc
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
This press release may include forward-looking information within the meaning of Canadian securities legislation concerning the business of BioNeutra. Forward-looking information is based on certain key expectations and assumptions made by the management of BioNeutra. Although BioNeutra believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because BioNeutra can give no assurance that they will prove to be correct. Forward-looking statements contained in this press release are made as of the date of this press release. BioNeutra disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.
This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in the United States. The securities described herein have not been and will not be registered under the United States Securities Act of 1933, as amended, or any applicable securities laws or any state of the United States and may not be offered or sold in the United States or to the account or benefit of a person in the United States absent an exemption from the registration requirements.